Organic Chemistry TRIZ Cases

Novel 1,2-diketone electrochromic compounds expand voltage-driven transmittance change for smart windows, mirrors, and displays.

Selective PAPD5 inhibition raises TERC and telomerase activity to restore telomere elongation while limiting off-target RNA effects.

By tuning LUMO energy with a heterocyclic emitter, OLEDs balance charge injection and keep efficiency and color stable across current densities.

Targeting EphA2 and EphB receptors with NVP-based inhibitors helps suppress colorectal tumor growth and overcome anti-EGFR resistance.

Blocking the RPA-DNA interaction prevents DNA repair in cancer cells, boosting platinum therapy and other DNA damaging treatments.

A cyclic thiocarbonate and amine adhesive system cures at room temperature, reducing isocyanate risk while forming resilient bonds.

Carbonate bonds in the epoxy network preserve thermal and mechanical properties while enabling amine-triggered chemical recycling.

Peptidomimetic GLP-1R agonists replace injections with oral dosing while improving insulin secretion and post-prandial glucose regulation.

Pyrazine-modified FXR agonists improve solubility, permeability, and oral bioavailability while maintaining strong activity for NAFLD treatment.

Specific emitting-layer compound combinations tune electroluminescence to raise luminous efficiency without sacrificing OLED device lifetime.

Targeting SETD2 in WHSC1-overexpressing cancers suppresses H3K36me3, reduces proliferation, and addresses relapse and drug resistance.

Triazine lipids in non-viral vectors inhibit canonical NFkB activity to balance TH1/TH2 responses while reducing vaccine reactogenicity.

By combining polyester blocks with ring-opened polyamide blocks, this copolymer improves moldability without losing mechanical strength.

Purely organic molecules with triazine, carbazole, and dibenzofuran units raise blue-green OLED quantum yield and thermal stability.

Specific onium salt chemistry improves acid diffusion control, sensitivity, LWR, CDU, and defect performance in fine resist pattern formation.

Liposome delivery of TSPO-binding photosensitizers improves mitochondrial tumor targeting while limiting side effects on normal cells.

Site-specific SHC mutations raise conversion rate and selectivity when cyclizing homofarnesol and bishomofarnesol into fragrance compounds.

Piperidinyl-methylpurine benzene compounds inhibit NSD2 to treat aggressive cancers while aiming to reduce side effects from current therapies.

Fluorinated acid-labile polymer design improves resist solubility, sensitivity, and contrast while limiting acid diffusion and pattern collapse.

New fused bicyclic compounds target pathogen G-quadruplexes to inhibit replication while retaining low cytotoxicity in human cells.

Enzymatic cleavage controls methadone release, helping deter misuse and overdose while improving treatment access and compliance.

A DMF-free pyroxasulfone process uses ethanol or isopropanol to cut hard-to-separate impurities and improve industrial solvent recovery.

Small molecule SARM1 inhibitors block NAD+ depletion to slow axonal degeneration in neurodegenerative disease.

Molecularly tuned OLED capping-layer material lowers refractive index and extinction to boost light extraction and reduce multi-angle color cast.

Amine-substituted spirobifluorene derivatives improve OLED hole transport and electron blocking while supporting longer life and lower voltage.

Novel TRIM21-binding ligands enable selective PROTAC protein degradation, improving target specificity for abnormal cell proliferation diseases.

Benzofurocarbazole heterocyclic materials improve hole transport and HOMO stability to lower OLED driving voltage and extend service life.

Formula I compounds stimulate autophagy with improved CNS selectivity, supporting treatment of cancer, age-related disease, and viral infection.

Temperature-controlled inert gas vaporization and electrostatic precipitation separate botanical oils without solvents or extra purification.

Pyridone-fused heterocyclic compounds address the shortage of Cbl-b inhibitors by enabling immune modulation for cancer and autoimmune therapy.

A floating gellan gum and alginate raft creates a long-lasting mechanical barrier that reduces gastric reflux and protects mucous membranes.

An MSM matrix turns oily cannabis extract into a stable powder for standardized dosage forms with improved bioavailability and easier manufacturing.

Benzothiazole urease inhibitors in melt-mixed or coated fertilizers curb ammonia volatilization and keep nitrogen loss below 20% over 21 days.

PPM-level compounds in xylylene diisocyanate raise resin heat resistance while supporting stable production of optical elements and lenses.

A single vacuum evaporation source co-deposits an organic compound and metal borate to improve layer uniformity, conductivity, and operating voltage.

Low-molecular-weight polyamine gadolinium chelates raise MRI relaxivity while supporting complete excretion, solubility, and chemical stability.

Bitopic ligands target orthosteric and allosteric receptor sites to improve D3R selectivity, reduce D2R cross-activation, and support functional studies.

Multi-stage extraction combines supercritical CO2, hydrolysis, and counter-current purification to raise capsanthin-rich carotenoid purity and yield.

Novel CYP4 inhibitors balance stability, solubility, and BBB penetration to block 20-HETE formation for neuroprotection after ischemia.

Continuous crystallization of titanosilicate zeolites raises throughput and improves propylene oxide selectivity by reducing epoxidation by-products.

A short benzo[g]quinoline synthesis route replaces supercritical fluid chromatography with diastereomeric salt resolution to raise yield and cut solvent waste.

Selective Ras-binding compounds inhibit Ras-mediated tumor growth while reducing toxicity to normal cells in Ras-driven cancers.

A methoxyimino intermediate, reduction, and salt-based optical resolution make this pyrrolidine route suitable for industrial chiral production.

Selective HDAC11 inhibitors suppress cancer stem cell-like proliferation and survival while lowering SOX2 and STAT3 expression.

Selective MC2R antagonists target ACTH-driven glucocorticoid excess while reducing side effects from non-specific melanocortin receptor modulation.

Selective MC2R antagonists suppress cortisol production while avoiding steroid buildup that causes side effects in glucocorticoid disorders.

Balancing ETL and HBL electromigration rates stabilizes OLED interfaces, reducing color drift and extending service life.

Novel hydrazone amide derivatives stimulate hair follicle growth for alopecia treatment while reducing toxicity and side effects seen with minoxidil and finasteride.

A compound-based photoelectric conversion film boosts external quantum efficiency and light response across red, green, and blue wavelengths.